Načítá se...

Antisickling Drugs Targeting βCys93 Reduce Iron Oxidation and Oxidative Changes in Sickle Cell Hemoglobin

Sickle cell disease is a genetic blood disorder caused by a single point mutation in the β globin gene where glutamic acid is replaced by valine at the sixth position of the β chain of hemoglobin (Hb). At low oxygen tension, the polymerization of deoxyHbS into fibers occurs in red blood cells (RBCs)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Physiol
Hlavní autoři: Kassa, Tigist, Wood, Francine, Strader, Michael Brad, Alayash, Abdu I.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668304/
https://ncbi.nlm.nih.gov/pubmed/31396101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2019.00931
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!